Education
About Us
Working with TipRanks
Follow Us
IQVIA Holdings Inc (IQV)
NYSE:IQV
IQV Stock Chart & Stats
$225.85
-$0.07(-0.03%)
At close: 4:00 PM EST
$225.85
-$0.07(-0.03%)
Day’s Range― - ―
52-Week Range$134.65 - $234.30
Previous CloseN/A
Volume300.39K
Average Volume (3M)1.55M
Market Cap
$38.46B
Enterprise Value$45.96B
Total Cash (Recent Filing)$1.97B
Total Debt (Recent Filing)$15.19B
Price to Earnings (P/E)31.0
Beta0.83
Next Earnings
Feb 18, 2026EPS Estimate
3.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.00
Shares Outstanding170,300,000
10 Day Avg. Volume1,388,881
30 Day Avg. Volume1,553,348
Financial Highlights & Ratios
PEG Ratio10.65
Price to Book (P/B)5.87
Price to Sales (P/S)2.31
P/FCF Ratio16.85
Enterprise Value/Market Cap1.19
Enterprise Value/Revenue2.89
Enterprise Value/Gross Profit8.56
Enterprise Value/Ebitda13.38
Forecast
1Y Price Target
$238.67Price Target Upside5.68% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)11.89
Revenue Forecast (FY)$16.19B
Bulls Say, Bears Say
Bulls Say
AI And Data InvestmentsIQV has invested aggressively in AI and other tools to extract increasingly valuable insights, enhancing all facets of drug development and commercialization.
Earnings GrowthThe worst of the cancellations are now behind IQV, paving the way for a re-acceleration in EPS and valuation into 2026.
Market PositionIQV is the largest global CRO, helping biopharma clients develop and commercialize drugs more quickly and efficiently.
Bears Say
Biotech Funding RisksWeak biotech funding poses a risk to CROs, including IQVIA, as it could lead to challenges if the trend continues for an extended period.
Margin PressuresMargin headwinds in the RDS business could restrict IQV's ability to achieve meaningful adjusted EBITDA growth in 2026.
Valuation ConcernsIQV's current valuation is considered to be fairly full, indicating limited potential for further stock price appreciation.
IQVIA Holdings News
IQV FAQ
What was IQVIA Holdings Inc’s price range in the past 12 months?
IQVIA Holdings Inc lowest stock price was $134.65 and its highest was $234.29 in the past 12 months.
What is IQVIA Holdings Inc’s market cap?
IQVIA Holdings Inc’s market cap is $38.46B.
When is IQVIA Holdings Inc’s upcoming earnings report date?
IQVIA Holdings Inc’s upcoming earnings report date is Feb 18, 2026 which is in 72 days.
How were IQVIA Holdings Inc’s earnings last quarter?
IQVIA Holdings Inc released its earnings results on Oct 28, 2025. The company reported $3 earnings per share for the quarter, beating the consensus estimate of $2.982 by $0.018.
Is IQVIA Holdings Inc overvalued?
According to Wall Street analysts IQVIA Holdings Inc’s price is currently Undervalued.
Does IQVIA Holdings Inc pay dividends?
IQVIA Holdings Inc does not currently pay dividends.
What is IQVIA Holdings Inc’s EPS estimate?
IQVIA Holdings Inc’s EPS estimate is 3.4.
How many shares outstanding does IQVIA Holdings Inc have?
IQVIA Holdings Inc has 170,300,000 shares outstanding.
What happened to IQVIA Holdings Inc’s price movement after its last earnings report?
IQVIA Holdings Inc reported an EPS of $3 in its last earnings report, beating expectations of $2.982. Following the earnings report the stock price went up 0.322%.
Which hedge fund is a major shareholder of IQVIA Holdings Inc?
Currently, no hedge funds are holding shares in IQV
IQVIA Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$238.67 (5.68% Upside)
$238.67 (5.68% Upside)
Blogger Sentiment
Bullish
IQV Sentiment 66%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $13.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.96%
12-Months-Change
Fundamentals
Return on Equity
19.55%
Trailing 12-Months
Asset Growth
5.69%
Trailing 12-Months
Company Description
IQVIA Holdings Inc
IQVIA Holdings Inc. is a global leader in health information technology and clinical research services, providing data-driven insights and solutions to the healthcare and life sciences sectors. The company operates through two primary segments: Technology & Analytics Solutions and Contract Research Services. IQVIA's core products and services include advanced analytics, technology solutions, and consulting services that enable pharmaceutical and biotech companies to optimize their R&D processes, enhance patient engagement, and improve clinical outcomes.
IQV Company Deck
IQV Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call conveyed a generally positive sentiment with strong financial performance, record-high free cash flow, and significant growth in net bookings and backlog. However, there were some challenges, particularly in the R&D Solutions segment and delays in mega trials. The company's focus on AI and technology advancements points to optimism for future efficiencies and growth.View all IQV earnings summariesIQV Revenue Breakdown
55.35% Research & Development Solutions
39.99% Technology & Analytics Solutions
4.66% Contract Sales & Medical Solutions
IQV Stock 12 Month Forecast
Average Price Target
$238.67
▲(5.68% Upside)
Technical Analysis
Ownership Overview
0.89% Insiders
25.75% Mutual Funds
17.98% Other Institutional Investors
30.36% Public Companies and
Individual Investors